đź“… Tuesday, August 25, 2026
⏰ 11AM PT / 12PM MT / 1PM CT / 2PM ET
📍 Virtual — Join from anywhere
👉 Register now!
For young adults, a cancer diagnosis often intersects with a pivotal time for identity, relationships, and family planning. These topics are deeply personal, yet they are frequently overlooked in standard clinical settings. This session provides a safe, clinical space to discuss how treatment impacts your reproductive future and family planning
We’re bringing in a top expert to provide “real-talk” and medical clarity on fertility preservation and family planning options. Whether you are navigating medically-induced menopause, concerned about family planning post-treatment, or looking to reclaim your sense of self in your relationships, this call is designed to give you agency over your body and your future.
What You’ll Learn:
- Fertility Foundations: A look at how different treatments impact reproductive health and the options available for preservation and family building.
- Managing Hormonal Shifts: Strategies for handling the physical and emotional effects of treatment-related hormonal changes.
- Navigating Communication: Tools for talking to partners and medical teams about your needs and concerns regarding intimacy.
About Our Speaker:
Douglas Fair, MD, MS, FAAP, is an Associate Professor of Pediatrics at the University of Utah and Director of the Primary Children’s Hospital Solid Tumor Program. As the Founder and Medical Director of the AYA Cancer Survivorship Program at Primary Children’s and Co-Medical Director of the Huntsman Intermountain Adolescent and Young Adult (HIAYA) Program, he is a leading voice in adolescent and young adult oncology. He is also the Founder and Co-Medical Director of the joint Oncofertility Programs across the University of Utah, Primary Children’s Hospital, and Huntsman Cancer Institute, and serves as a leader in the Oncofertility Consortium. Nationally, Dr. Fair contributes to the Children’s Oncology Group and NCCN AYA Guideline Committees, and his clinical research focuses heavily on long-term survivorship, gonadal and fertility function, and protecting reproductive health during cancer therapy.